Learning to associate cues or contexts with potential threats or rewards is adaptive and
enhances survival. Both aversive and appetitive memories are therefore powerful drivers of …

Anxiety and depression are pathologies that affect human beings in many aspects of life,
including social life, productivity and health. Cannabidiol (CBD) is a constituent non …

Post-traumatic stress disorder (PTSD) is characterized by poor adaptation to a traumatic
experience. This disorder affects approximately 10% of people at some point in life. Current …

Abstract Purpose of Review Anxiety-and trauma-related disorders are prevalent and
debilitating mental illnesses associated with a significant socioeconomic burden. Current …

The psychoactive component of the cannabis resin and flowers, delta9-
tetrahydrocannabinol (THC), was first isolated in 1964, and at least 70 other structurally …

Cannabidiol (CBD), a non-psychotomimetic compound of the Cannabis sativa, has been
reported to have central therapeutic actions, such as antipsychotic and anxiolytic effects. We …

Schizophrenia is a chronic mental disorder that disturbs feelings and behavior. The
symptoms of schizophrenia fall into three categories: positive, negative, and cognitive …

Although research has only recently started to examine the impact of cannabis use on stress
response, there is some evidence that indicates acute and chronic impacts of cannabis on …

Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that presents
antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects. In Parkinson's …

Schizophrenia is considered a debilitating neurodevelopmental psychiatric disorder and its
pharmacotherapy remains problematic without recent major advances. The development of …